028sek
0,7 %
Date:2024-07-24Time:17:29:37Latest report:Q1-2024List:First NorthTicker:BIOVIT
Market Cap:82 msekEnterprise Value:80 msekNet Sales:2,59 msekEarnings:-12,9 msekEmployees:0ISIN:SE0009320278

Ratios

10-year key figure history for Bio Vitos Pharma turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Bio Vitos Pharma with index and moving average MA50 and MA200.

Stockprice:0,28
MA50:0,15
MA200:0,19
Price/MA200:44,6 %
RSI (14):70,1
Price/MA50:83,9 %

Description

Bio Vitos Pharma develops, produces and commercializes iron succinate for the treatment of iron deficiency within the framework of the parent company as well as a service for close-to-patient detection of hemolysis in blood samples within the framework of a wholly owned subsidiary, Hemcheck Management AB.

Medical Equipment